IP Library Granted Patent US 7,323,310
Granted Patent B2
US 7,323,310 · App. 11/217,972 · Granted Jan 29, 2008

Methods and compositions for RNA amplification and detection using an RNA-dependent RNA-polymerase

Assignee: Qiagen North American Holdings, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,323,310
App. No.
11/217,972
Granted
Jan 29, 2008
Kind
B2
Abstract

Methods and compositions are provided for amplifying RNA from an RNA template. Methods and compositions are further provided for detecting an RNA in an RNA containing sample. Compositions used for the amplification of RNA from RNA include a RNA-dependent RNA-polymerase, a RNA helicase, and an energy source. Illustrative RNA-dependent RNA-polymerase enzymes are derived from the tomato or tobacco plant, while illustrative RNA helicase enzymes include the eIF4A and eIF4B proteins.

Claims (19)

1. An amplification reaction mixture for selectively amplifying RNA from a target RNA template comprising: a cellular RNA-dependent RNA-polymerase and at least two primers complementary to said target RNA template; wherein the RNA-dependent RNA-polvmerase is encoded by a nucleic acid sequence comprising SEQ ID NO:1.

2. The reaction mixture of claim 1 , wherein said primers are RNA primers.

3. The reaction mixture of claim 1 , wherein the cellular RNA-dependent RNA-polymerase is a recombinant cellular RNA-dependent RNA-polymerase.

4. The reaction mixture of claim 1 further comprising an RNA helicase.

5. The reaction mixture of claim 4 , wherein the RNA helicase is eIF4A.

6. The reaction mixture of claim 4 , further comprising an RNA helicase accessory protein.

7. An RNA amplification kit for selectively amplifying KNA from a target RNA template comprising: a cellular RNA-dependent RNA-polymerase and at least two primers complementary to said target RNA template; wherein the RNA-dependent RNA-polymerase is encoded by a nucleic acid secjuence comprising SEQ ID NO:1.

8. The kit of claim 7 further comprising an RNA helicase.

9. The kit of claim 8 further comprising an RNA helicase accessory protein.

10. A method for selectively amplifying RNA from an RNA template, comprising:

contacting the template RNA with an amplification reaction mixture according to claim 1 ; and

incubating said amplification reaction mixture to produce amplified RNA product,

wherein said incubation step comprises at least one denaturation condition.

11. The method of claim 10 wherein the RNA-dependent RNA-polymerase utilizes oligonucleotide primer-dependent transcription initiation.

12. The method of claim 10 wherein the RNA-dependent RNA-polymerase is a recombinant RNA-dependent RNA-polymerase.

13. The method of claim 10 wherein the primer is composed of RNA.

14. The method of claim 10 wherein the denaturation condition comprises a temperature cycling reaction.

15. The method of claim 10 , wherein the denaturation condition comprises an enzymatic denaturation reaction.

16. The method of claim 15 , wherein the amplification reaction mixture further comprises an RNA helicase.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 23, 2007
From: EPPENDORF AG
To: QIAGEN NORTH AMERICAN HOLDINGS, INC.
Reel/Frame 018923/0314 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 21, 2005
From: PETERS, LARS-ERIK; DOMANICO, MICHAEL; BUELOW, SVEN
To: EPPENDORF AG
Reel/Frame 017137/0494 →
Continuity (2)
Provisional Application 6060622200 · Aug 31, 2004
Related Publication 20060073500A1 · Apr 6, 2006